{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AU-011", "query": { "intervention": "AU-011" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T14:37:29.646Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03052127", "title": "Study in Subjects With Small Primary Choroidal Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Uveal Melanoma", "Ocular Melanoma", "Choroidal Melanoma" ], "interventions": [ { "name": "Light-activated AU-011", "type": "DRUG" }, { "name": "Laser Activation", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2017-02-27", "completion_date": "2021-01-26", "has_results": true, "last_update_posted_date": "2024-02-01", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 13, "location_summary": "Tucson, Arizona • Los Angeles, California • Palo Alto, California + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03052127" }, { "nct_id": "NCT07338968", "title": "A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Choroidal Melanoma", "Indeterminate Lesions" ], "interventions": [ { "name": "Observational", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-03-27", "completion_date": "2033-08-15", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 10, "location_summary": "Sacramento, California • Ann Arbor, Michigan • Rochester, Minnesota + 7 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07338968" }, { "nct_id": "NCT04417530", "title": "Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uveal Melanoma", "Ocular Melanoma", "Choroidal Melanoma" ], "interventions": [ { "name": "AU-011", "type": "DRUG" }, { "name": "Suprachoroidal Microinjector", "type": "DEVICE" }, { "name": "PDT Laser", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2020-08-05", "completion_date": "2024-04-22", "has_results": false, "last_update_posted_date": "2025-03-03", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 22, "location_summary": "Tucson, Arizona • Los Angeles, California • Palo Alto, California + 19 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04417530" }, { "nct_id": "NCT06007690", "title": "A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Choroidal Melanoma", "Indeterminate Lesions", "Uveal Melanoma", "Ocular Melanoma" ], "interventions": [ { "name": "Bel-sar", "type": "DRUG" }, { "name": "Suprachoroidal Microinjector", "type": "DEVICE" }, { "name": "Infrared Laser", "type": "DEVICE" }, { "name": "Sham Infrared Laser", "type": "DEVICE" }, { "name": "Sham Microinjector", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2023-12-06", "completion_date": "2028-08-15", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 32, "location_summary": "La Jolla, California • Los Angeles, California • Palo Alto, California + 27 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06007690" }, { "nct_id": "NCT06643884", "title": "Suprachoroidal Administration in Subjects With Metastases to the Choroid", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Eye Cancer", "Primary Cancer" ], "interventions": [ { "name": "AU-011", "type": "DRUG" }, { "name": "SCS Microinjector", "type": "DEVICE" }, { "name": "Laser", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2024-12-16", "completion_date": "2027-10-31", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 10, "location_summary": "Palo Alto, California • Miami, Florida • Boston, Massachusetts + 7 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06643884" }, { "nct_id": "NCT05266430", "title": "Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Choroidal Melanoma", "Indeterminate Lesions" ], "interventions": [ { "name": "Standard of Care", "type": "OTHER" }, { "name": "AU-011", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2022-04-14", "completion_date": "2023-04-20", "has_results": false, "last_update_posted_date": "2023-08-09", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 7, "location_summary": "Royal Oak, Michigan • Portland, Oregon • Greenville, South Carolina + 4 more", "locations": [ { "city": "Royal Oak", "state": "Michigan" }, { "city": "Portland", "state": "Oregon" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Bellaire", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05266430" }, { "nct_id": "NCT05483868", "title": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-muscle-invasive Bladder Cancer", "NMIBC", "Non-Muscle Invasive Bladder Carcinoma", "Non-Muscle Invasive Bladder Neoplasms", "Non-Muscle Invasive Bladder Urothelial Carcinoma", "Urothelial Carcinoma Bladder" ], "interventions": [ { "name": "AU-011", "type": "DRUG" }, { "name": "AU-011 in Combination with Medical Laser Adminstration", "type": "COMBINATION_PRODUCT" }, { "name": "AU-011 in Combination with Medical Laser Administration", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2022-09-26", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-09-02T14:37:29.646Z", "location_count": 13, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Santa Monica, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05483868" } ] }